FR2327781A2 - Nouveau derive anthranilique, son procede de preparation et son applica - Google Patents

Nouveau derive anthranilique, son procede de preparation et son applica

Info

Publication number
FR2327781A2
FR2327781A2 FR7531258A FR7531258A FR2327781A2 FR 2327781 A2 FR2327781 A2 FR 2327781A2 FR 7531258 A FR7531258 A FR 7531258A FR 7531258 A FR7531258 A FR 7531258A FR 2327781 A2 FR2327781 A2 FR 2327781A2
Authority
FR
France
Prior art keywords
anthranilate
quinolyl
trifluoromethylthio
dihydrochloride
dimethylaminoethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7531258A
Other languages
English (en)
French (fr)
Other versions
FR2327781B2 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7531258A priority Critical patent/FR2327781A2/fr
Publication of FR2327781A2 publication Critical patent/FR2327781A2/fr
Application granted granted Critical
Publication of FR2327781B2 publication Critical patent/FR2327781B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/44Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7531258A 1975-10-13 1975-10-13 Nouveau derive anthranilique, son procede de preparation et son applica Granted FR2327781A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7531258A FR2327781A2 (fr) 1975-10-13 1975-10-13 Nouveau derive anthranilique, son procede de preparation et son applica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7531258A FR2327781A2 (fr) 1975-10-13 1975-10-13 Nouveau derive anthranilique, son procede de preparation et son applica

Publications (2)

Publication Number Publication Date
FR2327781A2 true FR2327781A2 (fr) 1977-05-13
FR2327781B2 FR2327781B2 (enrdf_load_stackoverflow) 1978-08-25

Family

ID=9161117

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7531258A Granted FR2327781A2 (fr) 1975-10-13 1975-10-13 Nouveau derive anthranilique, son procede de preparation et son applica

Country Status (1)

Country Link
FR (1) FR2327781A2 (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
FR2327781B2 (enrdf_load_stackoverflow) 1978-08-25

Similar Documents

Publication Publication Date Title
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
NO944249L (no) Transdermal administrering av oksybutynin
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
DE69330032D1 (de) Therapeutisches kombinationspräparat enthaltend interferon
NO990279D0 (no) Isobutylgaba og dets derivater for behandling av smerte
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
ATE287271T1 (de) Verwendung von vegf zur herstellung eines medikaments zur behandlung oder verhinderung der intimalen hyperplasie und verabreichungsgerät
DE60138547D1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
DE69428523D1 (de) Verfahren zur behandlung von gemüts- oder geisteskrankheiten und von gemüts- oder geisteskrankheiten, die von anfällen begleitet sind
MC2078A1 (fr) Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires
SE7502341L (sv) N-1(1-bensylpyrollidinyl-2-alkyl)-substituerade bensylamider samt förfarande för framställning därav
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE193648T1 (de) Antipyretische und analgetische verfahren und zusammensetzungen, die optisch reines r-etodolac enthalten
FR2327781A2 (fr) Nouveau derive anthranilique, son procede de preparation et son applica
FR2417494A1 (fr) Nouvelles compositions analgesiques et antipyretiques contenant un derive de paracetamol
Phillips Collaboration with one's client.
CN211535628U (zh) 一种全砭石艾灸罐
AT351667B (de) Geraet zur therapeutischen behandlung und aktiven massage von muskeln
ES361664A1 (es) Procedimiento para la preparacion de nuevo acido antrani- lico.
JP2001288077A (ja) カプサイシンを利用した慢性前立腺炎、前立腺肥大症、痔疾及び勃起不全治療剤
RU2161477C2 (ru) Способ профилактики рецидива язвенной болезни двенадцатиперстной кишки
RU94042022A (ru) Лекарственное средство для лечения ишемии мозга
RU94002982A (ru) Способ лечения остеоартроза
SU718107A1 (ru) Способ лечени больных гипоталамическим синдромом вегетативно-сосудистой формы
DE3772764D1 (de) Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl)-methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung.